Dual-Uses Unapproved Effects of Gmos on the Environment. the Risk
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
U.S. V. Bayer AG and Monsanto Company Comment: the Sierra Club
ATTN: Kathleen S. O'Neill Chief, Transportation, Energy & Agriculture Section Antitrust Division United States Department of Justice 450 5th Street, NW, Suite 800 Washington, DC 20530 Petition in opposition to proposed U.S. v. Bayer AG and Monsanto Company settlement and merger: A merger of agrochemical giants Bayer and Monsanto would create the world's largest seed and pesticide maker. I am afraid this move will reduce competition, raise prices for consumers and farmers, and result in an unacceptable degree of control over the agricultural industry and our food supply. I am very concerned about pollinators and the increased risks to bees, butterflies and birds with the increase of Bayer's neonicotinoids. Both companies produce corn products engineered to imply the use of harmful pesticides they manufacture. The production of corn uses high amounts of nitrogen- based fertilizers and the excess sediment is contaminating our waterways, therefore I am deeply worried about increased corn production from this merger. The heavy nutrient runoff from corn is widely attributed to exacerbating the marine "Dead Zone" in the Gulf of Mexico, in which algal blooms create hypoxic conditions wherein oxygen concentration is in such low levels that marine life suffocates and dies. I urge the Department of Justice to do more prevent the Bayer-Monsanto seed and pesticide platform from growing too strong by stopping this merger. If this merger is allowed, it should require more pesticide and seed divestments in order to protect our agriculture and food supply. This merger is anti-competition, if it is approved it will fail to protect farmers, consumers and the environment by allowing further consolidation of the industrial agriculture sector. -
The Era of Corporate Consolidation and the End of Competition Bayer-Monsanto, Dow-Dupont, and Chemchina-Syngenta
Research Brief October 2018 The Era of Corporate Consolidation and the End of Competition Bayer-Monsanto, Dow-DuPont, and ChemChina-Syngenta DISRUPT ECOSYSTEM ACCLERATE MONOPOLY THE EFFECTS OF CORPORATE CONSOLIDATION UNDERMINE FOOD SECURITY HARM SMALL PRODUCERS HAASINSTITUTE.BERKELEY.EDU This publication is published by the Haas Institute for a Fair and Inclusive Society at UC Berkeley This research brief is part of the Haas Institute's Shahidi Project from the Global Justice Program. The Shahidi Project (Shahidi is a Swahili word meaning “witness”) intends to demystify the power structures and capacities of transnational food and agricultural corporations within our food system. To that end, researchers have developed a robust database focusing on ten of the largest food and agricultural corporations in the world. See more at haasinstitute.berkeley.edu/shahidi. About the Authors Copyeditor Support Elsadig Elsheikh is the director Marc Abizeid Special thanks to the Food of the Global Justice program and Farm Communications at the Haas Institute for a Infographics Fund, which provided the seed Fair and Inclusive Society at Samir Gambhir funding for the Shahidi project. the University of California- Berkeley, where he oversees Report Citation Contact the program’s projects and Elsadig Elsheikh and Hossein 460 Stephens Hall research on corporate power, Ayazi. “The Era of Corporate Berkeley, CA 94720-2330 food system, forced migration, Consolidation and The End of Tel 510-642-3326 human rights, Islamophobia, Competition: Bayer-Monsanto, haasinstitute.berkeley.edu structural marginality and Dow-DuPont, and ChemChina- inclusion, and trade and Syngenta.” Haas Institute for development. a Fair and Inclusive Society at the University of California, Hossein Ayazi, PhD, is a Berkeley, CA. -
List of Active Bayer Companies with at Least a Share of 50% Last Update: 17.8.2020 Country Company
List of active Bayer companies with at least a share of 50% last update: 17.8.2020 Country Company Algeria Bayer Algerie S.P.A. Argentina Bayer S.A. Argentina Biagro S.A. Argentina Monsanto Argentina SRL Australia Bayer Australia Limited Australia Bayer CropScience Holdings Pty Ltd Australia Bayer CropScience Pty Limited Australia Cotton Growers Services Pty. Limited Australia Imaxeon Pty. Ltd. Australia Monsanto Australia Pty Ltd Bangladesh Bayer CropScience Ltd. Belgium Bayer Agriculture BVBA Belgium Bayer CropScience NV Belgium Bayer NV Bermuda MonSure Limited Bolivia Bayer Boliviana Ltda Bolivia Monsanto Bolivia S.A. Bosnia & Herzeg. Bayer d.o.o. Sarajevo Brazil Alkagro do Brasil Ltda Brazil Bayer S.A. Brazil D&PL Brasil Ltda Brazil Monsanto do Brasil Ltda. Brazil Rede Agro Fidelidade e Intermediacao S.A. Brazil Schering do Brasil Química e Farmacêutica Ltda. Brazil Stoneville Brasil Ltda. Bulgaria Bayer Bulgaria EOOD Burkina Faso Monsanto Burkina Faso SARL Chile Bayer Finance & Portfolio Management S.A. Chile Bayer Finance Ltda. Chile Bayer S.A. Chile Monsanto Chile, S.A. Costa Rica Bayer Business Services Costa Rica, SRL Costa Rica Bayer Medical S.R.L. Costa Rica Bayer S.A. Curacao Pianosa B.V. Germany Adverio Pharma GmbH - 1 - List of active Bayer companies with at least a share of 50% last update: 17.8.2020 Country Company Germany AgrEvo Verwaltungsgesellschaft mbH Germany Alcafleu Management GmbH & Co. KG Germany BGI Deutschland GmbH Germany Bayer 04 Immobilien GmbH Germany Bayer 04 Leverkusen Fußball GmbH Germany Bayer 04 Leverkusen -
Whither Plant Genetic Engineering? Allow Crops to Tolerate Environmental Stress Such As Drought, Cold, Salt, Heat, Or flood
PLANT TREK TO BOLDLY GO WHERE NO PLANT HAS GONE BEFORE On the Past, Present & Future of Plant Genetic Engineering by Richard G. Stout A HowPlantsWork.com eBook Copyright © 2013 by Richard G. Stout Version 1.0.1 PDF August, 2013 Table of Contents Preface Chapter 1: Where Do New Plants Come From? Chapter 2: How To Make A Transgenic Plant Chapter 3: Gene Guns, Terminators & Traitors Chapter 4: Farmaceuticals, Plantibodies & Edible Vaccines Chapter 5: Into The Wild Chapter 6: Are GM Plants Self-Replicating Inventions? Chapter 7: Plant Trek - The Next Generation Chapter 8: DIY Plant Genetic Engineering? Attributions About The Author Glossary about where plant biotechnology may be headed in the future, Preface including how plant biotechnology “hobbyists” may be getting into the act. Who is this book for? Please Note: This book is NOT a comprehensive textbook on plant genetic engineering and biotechnology. (If you’re looking This book is intended for people who may be curious about for such books, I’m sure you can find them at your local college plant genetic engineering, but who don’t want to read a long, bookstore or at an online bookseller.) Nor is this book meant to technical textbook on the subject. (There are provided, be a defense of genetically-engineered organisms (GMOs), however, ample links to books and articles - and also to online though I’m sure some readers will think so. Maybe here’s why. resources - for further reading.) If you’re looking for small “tastes” of information regarding various aspects of plant Since I was a graduate student in the 1970s at the University of genetic engineering, then this little book maybe just the Washington where some of the original work on transgenic informational “snack” that you’re looking for. -
Agribusiness and Antitrust: the Bayer-Monsanto Merger, Its Legality, and Its Effect on the United States and European Union
The Global Business Law Review Volume 7 Issue 1 Article 9 7-1-2018 Agribusiness and Antitrust: The Bayer-Monsanto Merger, Its Legality, and Its Effect on the United States and European Union Aleah Douglas Cleveland-Marshall College of Law Follow this and additional works at: https://engagedscholarship.csuohio.edu/gblr Part of the Antitrust and Trade Regulation Commons, and the Business Organizations Law Commons How does access to this work benefit ou?y Let us know! Recommended Citation Aleah Douglas, Agribusiness and Antitrust: The Bayer-Monsanto Merger, Its Legality, and Its Effect on the United States and European Union, 7 Global Bus. L. Rev. 156 (2018) available at https://engagedscholarship.csuohio.edu/gblr/vol7/iss1/9 This Note is brought to you for free and open access by the Journals at EngagedScholarship@CSU. It has been accepted for inclusion in The Global Business Law Review by an authorized editor of EngagedScholarship@CSU. For more information, please contact [email protected]. AGRIBUSINESS AND ANTITRUST: THE BAYER-MONSANTO MERGER, ITS LEGALITY, AND ITS EFFECT ON THE UNITED STATES AND EUROPEAN UNION ALEAH DOUGLAS I. INTRODUCTION……………………………………………………………………... 157 II. BACKGROUND…………………………………………………………………….....158 A. A Review of the Bayer-Monsanto Merger………………………….…………... 158 B. United States Antitrust Laws…………………………………………………… 161 1. The Applicable Laws……………………………………………………. 161 2. Problems and Antitrust Violations……………………………………… 166 3. American Agribusiness…………………………………………………. 167 C. European Union Antitrust Laws……………………………………………….. 172 1. The European Union……………………………………………………. 172 2. The Applicable Laws………………………………….………………… 172 3. Problems and Antitrust Violations……………………….………....…... 174 4. European Union Agribusiness…………….…………………………….. 176 D. Illegality and Detriment …………………………………….…………………. 178 III. CONCLUSION……………………………………………………………………....... 180 ABSTRACT This note examines the current and historical antitrust laws of the United States and the European Union as they relate to the currently pending merger between Bayer and Monsanto. -
The Bio Revolution: Innovations Transforming and Our Societies, Economies, Lives
The Bio Revolution: Innovations transforming economies, societies, and our lives economies, societies, our and transforming Innovations Revolution: Bio The The Bio Revolution Innovations transforming economies, societies, and our lives May 2020 McKinsey Global Institute Since its founding in 1990, the McKinsey Global Institute (MGI) has sought to develop a deeper understanding of the evolving global economy. As the business and economics research arm of McKinsey & Company, MGI aims to help leaders in the commercial, public, and social sectors understand trends and forces shaping the global economy. MGI research combines the disciplines of economics and management, employing the analytical tools of economics with the insights of business leaders. Our “micro-to-macro” methodology examines microeconomic industry trends to better understand the broad macroeconomic forces affecting business strategy and public policy. MGI’s in-depth reports have covered more than 20 countries and 30 industries. Current research focuses on six themes: productivity and growth, natural resources, labor markets, the evolution of global financial markets, the economic impact of technology and innovation, and urbanization. Recent reports have assessed the digital economy, the impact of AI and automation on employment, physical climate risk, income inequal ity, the productivity puzzle, the economic benefits of tackling gender inequality, a new era of global competition, Chinese innovation, and digital and financial globalization. MGI is led by three McKinsey & Company senior partners: co-chairs James Manyika and Sven Smit, and director Jonathan Woetzel. Michael Chui, Susan Lund, Anu Madgavkar, Jan Mischke, Sree Ramaswamy, Jaana Remes, Jeongmin Seong, and Tilman Tacke are MGI partners, and Mekala Krishnan is an MGI senior fellow. -
CRISPR and the Future of Fertility Innovation
Science and Technology Law Review Volume 23 Number 1 Article 3 2020 CRISPR and the Future of Fertility Innovation June R. Carbone University of Minnesota Law School, [email protected] Follow this and additional works at: https://scholar.smu.edu/scitech Part of the Health Law and Policy Commons, and the Science and Technology Law Commons Recommended Citation June R Carbone, CRISPR and the Future of Fertility Innovation, 23 SMU SCI. & TECH. L. REV. 31 (2020) https://scholar.smu.edu/scitech/vol23/iss1/3 This Article is brought to you for free and open access by the Law Journals at SMU Scholar. It has been accepted for inclusion in Science and Technology Law Review by an authorized administrator of SMU Scholar. For more information, please visit http://digitalrepository.smu.edu. CRISPR and the Future of Fertility Innovation June Carbone* In 2018, Dr. He Jiankui announced that he had used CRISPR, a gene- editing tool, to produce newborn twin girls with the gene for HIV resistance.1 The announcement caused a global uproar. Dr. He appeared to have tried the procedure without advance testing.2 He did so without assurance the proce- dure was safe; indeed, unintended side effects could affect not only the twins but the twins’ own offspring.3 And he did it to otherwise healthy embryos.4 While the twins risked exposure to the HIV virus their father carried, less risky treatments exist that reduce the risk of transmission.5 Dr. He also tried the technique without following appropriate Chinese protocols.6 As a result of the outcry that followed his announcement, use of the procedure in China has been effectively shut down.7 This leaves open the question: if CRISPR is to be used again in the reproductive context, how and why is it to occur? CRISPR creates new possibilities for genetic engineering, which alters a person’s—or an embryo’s—genetic inheritance in ways that alter the germline, in turn passing on the alterations to subsequent generations. -
CRISPR Technology; Advantages, Limitations and Future Direction
nd Ph l a arm Omodamilola and Ibrahim, J Biomed Pharm Sci 2018, 1:2 a a ic c d e e u m t i o c Journal of i a B l S f o c l i e a n n c r e u s o J Biomedical and Pharmaceutical Sciences Review Article Open Access CRISPR Technology: Advantages, Limitations and Future Direction Omoyayi Ibrahim Omodamilola* and Abdullahi Umar Ibrahim Department of Biomedical Engineering, Near East University, Mersin 10, Turkey Abstract The evolutionary discovery of CRIPRS technology has paved the way for researchers in various fields’ genetics, medicine, pharmacy and computer science. Its potential application is limitless spanning from therapy of disease such as cancer and immunotherapy with gene silencing, gene knock down, gene KO, to the food production of genetically modified foods, the potential possibility of genetically designing baby using CRSIPR technology with enhanced trait and potential of eradicating Malaria and HIV-AIDS. The review thereby focuses on Off-targets limitation of the technology which is explained as one of the major constraint for application in clinical procedure with its hope of eradication through machine learning (ML). Further application of crisper technology was also discussed. Keywords: CRISPR; Designer Baby; Machine Learning; Off Targets; of an adaptive immune system and the discovery of Cas9 and PAM by Gene Knock out Bolotin. The process where bacterial CRISPR transcribed a guide RNA and form CRISPR-Cas9 Complex which not only store a record of Introduction invading bacteriophages and other viral DNA but also to destroy the The word “smart” has been the recent trend in almost all viruses upon second attack [6]. -
1 Designer Babies
Designer Babies: The Ethical and Societal Effects Andy Kromer College of Saint Benedict/Saint John’s University April 17, 2018 It’s a process; It dates back to 12,000 BC when human beings started domesticating animals. Unknowingly, at the time, we participated in an act of science: genetic modification. It is a process in which humans influence the genes of another specie. Many believe this process is the same as genetic engineering; however, there is a difference. Genetic engineering is defined as the artificial modification or manipulation of an organism’s nucleic acids or DNA. The difference is the matter in which the genes are manipulated. Through genetic modification, natural changes are made to a specie, while through genetic engineering, tools or technologies are used to modify or manipulate a certain gene. The process of genetic engineering isn’t natural. This is a key component that set these two terms apart, but they are very similar nonetheless. Background: Genetic Engineering Genetic engineering was first introduced nearly fifty years ago by Herbert Boyer and Stanley Cohen. At first, this technology was used on plants to increase the yield values of certain farm crops. Undoubtedly, it has provided a great advancement in the economy. Brookes and Barfoot (2014) found that since the first significant amounts of genetically modified crops were planted in 1996, there has been more than one hundred and sixty-six billion dollars generated from the agriculture industry. The production levels have also increased substantially. The success of GMOs and genetic engineering has sparked curiosity in the United States. -
Chapter 2: Benefits and Risks of Gene Technology in Agriculture
2 %HQHILWVDQGULVNVRIJHQHWHFKQRORJ\LQ DJULFXOWXUH Introduction 2.1 Using biotechnology can be seen as extending earlier methods of plant and animal breeding which date back many thousands of years (Table 2.1).1 The technology obtains results more rapidly, is more precise, and gives access to a broader genetic base than traditional breeding techniques. These are the features that recommend its use so powerfully to plant and animal breeders. It provides an important tool when integrated with traditional breeding approaches. 2.2 The precision that gene technology offers is possible because the exact segment of a chromosome that determines a desired trait can be identified. With this capacity, traditional breeding programs can be fast tracked by locating seeds or offspring at an early stage, through gene marker technology, and breeding only from them. The Cattle Council of Australia commented on the dramatic increases in precision of genetic improvement that is possible as a result.2 In addition, genes can be removed from one organism and inserted into another. 2.3 Transgenesis, in which genes are moved from one species or organism to another, allows beneficial genes from any source to be transferred to other species or organisms. The Cooperative Research Centre (CRC) for Tropical Plant Pathology pointed out that, while conventional breeding programs have improved the pest and disease resistance of Australian crops, there 1 C Hudson, 'How industry adopts new technology', Gene Technology and Food, National Science & Industry Forum Report, Australian Academy of Science, April 1999, p. 12; Nugrain, Submission no. 25, p. 6. 2 Cattle Council of Australia, Submission no. -
Are We Ready for Designer Babies? Analysis of Law, Policy and Ethics Surrounding Germline Genetic Engineering
MUMBAI SILICON VALLEY BANGALORE SINGAPORE MUMBAI BKC NEW DELHI MUNICH NEW YORK Are we ready for Designer Babies? Analysis of law, policy and ethics surrounding germline genetic engineering Strategic, Legal, Tax and Ethical issues June 2019 © Copyright 2019 Nishith Desai Associates www.nishithdesai.com Are we ready for Designer Babies? Analysis of law, policy and ethics surrounding germline genetic engineering Strategic, Legal, Tax and Ethical Issues June 2019 [email protected] DMS Code: No 480049v2 © Nishith Desai Associates 2019 Are we ready for Designer Babies? Analysis of law, policy and ethics surrounding germline genetic engineering About NDA At Nishith Desai Associates, we have earned the reputation of being Asia’s most Innovative Law Firm – and the go-to specialists for companies around the world, looking to conduct businesses in India and for Indian companies considering business expansion abroad. In fact, we have conceptualized and created a state-of-the-art Blue Sky Thinking and Research Campus, Imaginarium Aligunjan, an international institution dedicated to designing a premeditated future with an embedded strategic foresight capability. We are a research and strategy driven international firm with offices in Mumbai, Palo Alto (Silicon Valley), Bangalore, Singapore, New Delhi, Munich, and New York. Our team comprises of specialists who provide strategic advice on legal, regulatory, and tax related matters in an integrated manner basis key insights carefully culled from the allied industries. As an active participant in shaping India’s regulatory environment, we at NDA, have the expertise and more importantly – the VISION – to navigate its complexities. Our ongoing endeavors in conducting and facilitating original research in emerging areas of law has helped us develop unparalleled proficiency to anticipate legal obstacles, mitigate potential risks and identify new opportunities for our clients on a global scale. -
The Moral Dilemma of Genetically Modified Foods (Gmos)
Fordham University Masthead Logo DigitalResearch@Fordham Student Theses 2001-2013 Environmental Studies 2005 The orM al Dilemma of Genetically Modified Foods (GMOs) Anamarie Beluch Follow this and additional works at: https://fordham.bepress.com/environ_theses Part of the Environmental Sciences Commons Recommended Citation Beluch, Anamarie, "The orM al Dilemma of Genetically Modified Foods (GMOs)" (2005). Student Theses 2001-2013. 72. https://fordham.bepress.com/environ_theses/72 This is brought to you for free and open access by the Environmental Studies at DigitalResearch@Fordham. It has been accepted for inclusion in Student Theses 2001-2013 by an authorized administrator of DigitalResearch@Fordham. For more information, please contact [email protected]. The Moral Dilemma of Genetically Modified Foods (GMOs) By Anamarie Beluch Genetically modified (GM) foods are foods that are produced from genetically modified organisms (GMO) that have had their DNA altered through genetic engineering. The process of producing a GMO used for genetically modified foods involve taking DNA from one organism, modifying it in a laboratory, and then inserting it into the target organism's genome to produce new and useful genotypes or phenotypes. These techniques are generally known as recombinant DNA technology. In recombinant DNA technology, DNA molecules from different sources are combined in vitro into one molecule to create a new gene. This DNA is then transferred into an organism and causes the expression of modified or novel traits. Such GMOs are generally referred to as transgenic, which means pertaining to or containing a gene or genes from another species. There are other methods of producing a GMO, which include increasing or decreasing the number of copies of a gene already present in the target organism, silencing or removing a particular gene, or modifying the position of a gene within the genome.